Politician trade (Senate)

Ventas (VTR)Sen. Alan Armstrong disclosed a purchase $1K–$15K

Sen. Alan Armstrong disclosed a purchase of Ventas in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
116 days
Disclosure lag
Traded
Mar 27, 2026
Disclosed
Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 9, 2026CongressDisclosed partial sale of VTR — reported range $1,001 - $15,000
  2. Feb 2, 2026InsiderCEO sold ~$802K of VTR shares in the open market
  3. Feb 5, 2026Company filing · Form 8-K · ResultsReported its results
  4. Feb 6, 2026InsiderCEO sold ~$849K of VTR shares in the open market
  5. Feb 11, 2026Insider · 5 days before an 8-KOfficer sold ~$3.02M of VTR shares in the open market
  6. Feb 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 16, 2026, Gregory R. Liebbe, Senior Vice President, Chief Accounting Officer and Controller informed Ventas, Inc. (the “Company”) that he is resigning to pursue other opportunities.”
  7. Mar 27, 2026 · this disclosureCongressDisclosed purchase of VTR — reported range $1,001 - $15,000

What came next

  1. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  2. Apr 27, 2026Company filing · Form 8-K · ResultsReported its results
  3. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 8.7%
  4. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  5. May 4, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 7.1%
  6. May 12, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote (and 1 more item)“On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc. (the “Separation Agreement”), pursuant to which Mr. Bulgarelli will receive a payment equal to…”
  7. May 12, 20265% stakeJPMORGAN CHASE & CO reported a passive stake (13G) of 7.1%
  8. May 14, 2026InsiderDirector sold ~$104K of VTR shares in the open market
  9. Jun 3, 2026Insider · 12 days before an 8-KDirector purchased ~$197K of VTR shares in the open market
  10. Jun 15, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On June 15, 2026, Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary of Ventas, Inc. (“Ventas” or the “Company”) notified Ventas of her intention to resign from the Company effective June 26, 2026 (the “Effective Date”).”
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Ventas

For Ventas, OQRO holds 1 Congress trade report and 16 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTR page.

Other recent filings by Sen. Alan Armstrong

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

Other disclosures at Ventas

Everything OQRO holds on this company is on its VTR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data